BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 24636252)

  • 1. HIV cure research: advances and prospects.
    Passaes CP; Sáez-Cirión A
    Virology; 2014 Apr; 454-455():340-52. PubMed ID: 24636252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status and challenges of antiretroviral research and therapy.
    Esté JA; Cihlar T
    Antiviral Res; 2010 Jan; 85(1):25-33. PubMed ID: 20018390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.
    Chun TW; Fauci AS
    AIDS; 2012 Jun; 26(10):1261-8. PubMed ID: 22472858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current use of antiretroviral treatment.
    Bailey AC; Fisher M
    Br Med Bull; 2008; 87():175-92. PubMed ID: 18757468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in onychomycosis after initiation of combined antiretroviral therapy.
    Moreno-Coutiño G; Arenas R; Reyes-Terán G
    Int J Dermatol; 2013 Mar; 52(3):311-3. PubMed ID: 22998739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy.
    Cassol E; Malfeld S; Mahasha P; Bond R; Slavik T; Seebregts C; Poli G; Cassol S; van der Merwe SW; Rossouw T
    J Infect Dis; 2013 Oct; 208(7):1113-22. PubMed ID: 23749968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines for antiretroviral therapy of human immunodeficiency virus (HIV)-infected subjects in the Czech Republic].
    Sedlácek D; Stanková M; Machala L; Rozsypal H; Snopková S; Dostál V; Kolcáková J; Dlouhý P; Jerhotová Z
    Klin Mikrobiol Infekc Lek; 2007 Feb; 13(1):28-34. PubMed ID: 17417753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in antiretroviral therapy in HIV infection.
    Arora DR; Gautam V; Gill PS; Mishra N
    J Indian Med Assoc; 2010 Jan; 108(1):29-34. PubMed ID: 20839577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.
    Chaix ML; Seng R; Frange P; Tran L; Avettand-Fenoël V; Ghosn J; Reynes J; Yazdanpanah Y; Raffi F; Goujard C; Rouzioux C; Meyer L;
    Clin Infect Dis; 2013 Mar; 56(6):880-7. PubMed ID: 23223603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlights on HIV eradication in 2013.
    Monforte Ad; Svicher V; Nozza S; Lazzarin A; Marchetti G; Perno CF
    AIDS; 2014 Jan; 28(1):1-7. PubMed ID: 23939240
    [No Abstract]   [Full Text] [Related]  

  • 11. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
    Kwara A; Flanigan TP; Carter EJ
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral treatment: current approach and future prospects.
    Taiwo BO
    Afr J Med Med Sci; 2006 Dec; 35 Suppl():1-11. PubMed ID: 18050771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.
    Hocqueloux L; Avettand-Fènoël V; Jacquot S; Prazuck T; Legac E; Mélard A; Niang M; Mille C; Le Moal G; Viard JP; Rouzioux C;
    J Antimicrob Chemother; 2013 May; 68(5):1169-78. PubMed ID: 23335199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiretroviral treatment for HIV infection. Where we are and where we are going?].
    Sierra-Madero JG; Franco-San-Sebastián D
    Rev Invest Clin; 2004; 56(2):222-31. PubMed ID: 15377075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination antiretroviral therapy failure and HIV super-infection.
    Bezemer D; van Sighem A; de Wolf F; Cornelissen M; van der Kuyl AC; Jurriaans S; van der Hoek L; Prins M; Coutinho RA; Lukashov VV
    AIDS; 2008 Jan; 22(2):309-11. PubMed ID: 18097235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
    Moanna A; Rimland D
    Clin Infect Dis; 2013 Jul; 57(1):122-5. PubMed ID: 23487391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for treatment of latent HIV.
    Barton KM; Burch BD; Soriano-Sarabia N; Margolis DM
    Clin Pharmacol Ther; 2013 Jan; 93(1):46-56. PubMed ID: 23212106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will antiretroviral therapy reduce HIV-related liver risk?
    Allen J; Smith C; Bhagani S
    Curr Opin HIV AIDS; 2014 Jan; 9(1):48-53. PubMed ID: 24247670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvements in antiretroviral therapy outcomes over calendar time.
    Boyd MA
    Curr Opin HIV AIDS; 2009 May; 4(3):194-9. PubMed ID: 19532050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus prevalence and vaccine response in HIV-infected children and adolescents on combination antiretroviral therapy in Kigali, Rwanda.
    Mutwa PR; Boer KR; Rusine JB; Muganga N; Tuyishimire D; Reiss P; Lange JM; Geelen SP
    Pediatr Infect Dis J; 2013 Mar; 32(3):246-51. PubMed ID: 22976050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.